These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 7832136

  • 21. Oral estrogen replacement therapy increases forearm reactive hyperemia accompanied by increases in serum levels of nitric oxide in postmenopausal women.
    Sanada M, Higashi Y, Nakagawa K, Sasaki S, Kodama I, Sakashita T, Tsuda M, Ohama K.
    Gynecol Endocrinol; 2001 Apr; 15(2):150-7. PubMed ID: 11379012
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women.
    Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung AC, Creager MA.
    Ann Intern Med; 1994 Dec 15; 121(12):936-41. PubMed ID: 7978718
    [Abstract] [Full Text] [Related]

  • 24. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women.
    Guetta V, Quyyumi AA, Prasad A, Panza JA, Waclawiw M, Cannon RO.
    Circulation; 1997 Nov 04; 96(9):2795-801. PubMed ID: 9386140
    [Abstract] [Full Text] [Related]

  • 25. Rapid potentiation of endothelium-dependent vasodilation by estradiol in postmenopausal women is mediated via cyclooxygenase 2.
    Calkin AC, Sudhir K, Honisett S, Williams MR, Dawood T, Komesaroff PA.
    J Clin Endocrinol Metab; 2002 Nov 04; 87(11):5072-5. PubMed ID: 12414874
    [Abstract] [Full Text] [Related]

  • 26. Relation of baseline forearm vasodilator reserve to vascular endothelial response to estrogen replacement therapy in healthy postmenopausal women.
    Ilercil A, Freeman R, Lachmann J, Brofferio A, Scotton M, Lekaj P, Freitag A, Emerson M, LeJemtel TH, Shirani J.
    Am J Cardiol; 2002 May 01; 89(9):1139-41. PubMed ID: 11988212
    [No Abstract] [Full Text] [Related]

  • 27. Exercise as an alternative to oral estrogen for amelioration of endothelial dysfunction in postmenopausal women.
    Harvey PJ, Picton PE, Su WS, Morris BL, Notarius CF, Floras JS.
    Am Heart J; 2005 Feb 01; 149(2):291-7. PubMed ID: 15846267
    [Abstract] [Full Text] [Related]

  • 28. Relationship between the angiotensin-converting enzyme genotype and the forearm vasodilator response to estrogen replacement therapy in postmenopausal women.
    Sanada M, Higashi Y, Nakagawa K, Sasaki S, Kodama I, Tsuda M, Nagai N, Ohama K.
    J Am Coll Cardiol; 2001 May 01; 37(6):1529-35. PubMed ID: 11345361
    [Abstract] [Full Text] [Related]

  • 29. Tetrahydrobiopterin improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women.
    Moreau KL, Meditz A, Deane KD, Kohrt WM.
    Am J Physiol Heart Circ Physiol; 2012 Mar 01; 302(5):H1211-8. PubMed ID: 22245769
    [Abstract] [Full Text] [Related]

  • 30. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia.
    Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM.
    Lancet; 1992 Dec 12; 340(8833):1430-2. PubMed ID: 1360559
    [Abstract] [Full Text] [Related]

  • 31. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy.
    Herrington DM, Braden GA, Williams JK, Morgan TM.
    Am J Cardiol; 1994 May 15; 73(13):951-2. PubMed ID: 8184850
    [No Abstract] [Full Text] [Related]

  • 32. Plasma free fatty acids and endothelium-dependent vasodilation: effect of chain-length and cyclooxygenase inhibition.
    de Kreutzenberg SV, Crepaldi C, Marchetto S, Calò L, Tiengo A, Del Prato S, Avogaro A.
    J Clin Endocrinol Metab; 2000 Feb 15; 85(2):793-8. PubMed ID: 10690892
    [Abstract] [Full Text] [Related]

  • 33. Small artery endothelial dysfunction in postmenopausal women: in vitro function, morphology, and modification by estrogen and selective estrogen receptor modulators.
    Kublickiene K, Svedas E, Landgren BM, Crisby M, Nahar N, Nisell H, Poston L.
    J Clin Endocrinol Metab; 2005 Nov 15; 90(11):6113-22. PubMed ID: 16131583
    [Abstract] [Full Text] [Related]

  • 34. Effect of conjugated estrogen on peripheral flow-mediated vasodilation in postmenopausal women.
    Al-Khalili F, Eriksson M, Landgren BM, Schenck-Gustafsson K.
    Am J Cardiol; 1998 Jul 15; 82(2):215-8. PubMed ID: 9678294
    [Abstract] [Full Text] [Related]

  • 35. Effect of estrogen replacement therapy on insulin sensitivity of glucose metabolism and preresistance and resistance vessel function in healthy postmenopausal women.
    Vehkavaara S, Westerbacka J, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Yki-Järvinen H.
    J Clin Endocrinol Metab; 2000 Dec 15; 85(12):4663-70. PubMed ID: 11134125
    [Abstract] [Full Text] [Related]

  • 36. Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation.
    Kawano H, Motoyama T, Kugiyama K, Hirashima O, Ohgushi M, Fujii H, Ogawa H, Yasue H.
    J Am Coll Cardiol; 1997 Oct 15; 30(4):914-9. PubMed ID: 9316518
    [Abstract] [Full Text] [Related]

  • 37. Estrogen replacement therapy in postmenopausal women augments reactive hyperemia in the forearm by reducing angiotensin converting enzyme activity.
    Sanada M, Higashi Y, Nakagawa K, Sasaki S, Kodama I, Sakashita T, Tsuda M, Ohama K.
    Atherosclerosis; 2001 Oct 15; 158(2):391-7. PubMed ID: 11583718
    [Abstract] [Full Text] [Related]

  • 38. Effects of norepinephrine on endothelium-dependent vasodilation of forearm resistance vessels.
    Rector TS, Bank AJ, De Bruyn VH, Garr MD, Kraemer MD, Kubo SH.
    Clin Pharmacol Ther; 1993 Mar 15; 53(3):374-9. PubMed ID: 8453857
    [Abstract] [Full Text] [Related]

  • 39. Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women.
    Wakatsuki A, Ikenoue N, Shinohara K, Watanabe K, Fukaya T.
    Arterioscler Thromb Vasc Biol; 2004 Mar 15; 24(3):571-6. PubMed ID: 14699021
    [Abstract] [Full Text] [Related]

  • 40. Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease.
    Emre A, Sahin S, Erzik C, Nurkalem Z, Oz D, Cirakoglu B, Yesilcimen K, Ersek B.
    Cardiology; 2006 Mar 15; 106(1):44-50. PubMed ID: 16612068
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.